1
![Ambit Biosciences]()
![Ambit Biosciences]()
![Ambit Biosciences]()
Ambit Biosciences
Leadership team
Kevin Kinsella (Founder)
Products/ Services
Biopharma, Biotechnology, Health Care
Number of Employees
50 - 100
Headquarters
San Diego, California, United States
Established
2000
Company Registration
SEC CIK number: 0001131543
Traded as
NASDAQ:AMBI
Overview
Location
Summary
Ambit Biosciences is a biopharmaceutical company that discovers and develops small molecule drugs for treating cancer and autoimmune diseases.
History
Founded in 2002, Ambit Biosciences is focused on discovering and developing small molecule drugs for treating cancer and autoimmune diseases. Ambit is a wholly owned subsidiary of Tokyo-based Daiichi Sankyo, and has become a leader in developing novel therapies in these areas.
Mission
Our mission is to positively impact the lives of those affected by cancer and autoimmune diseases by discovering and developing novel therapies that improve outcomes.
Vision
Our vision is to revolutionize the treatment of these diseases with more effective medicines.
Key Team
Kevin Kinsella (Founder)
Recognition and Awards
Ambit Biosciences has been awarded numerous awards, including the Pharmacy Times Specialty Pharmacy of the Year in 2007, Plattner Award in 2010, and a Corporate Achievement Award from the California Biotechnology Foundation in 2012.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Kevin Kinsella (Founder)
Products/ Services
Biopharma, Biotechnology, Health Care
Number of Employees
50 - 100
Headquarters
San Diego, California, United States
Established
2000
Company Registration
SEC CIK number: 0001131543
Traded as
NASDAQ:AMBI